These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23522731)

  • 1. Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.
    Wilmot-Roussel H; Lévy DJ; Carette C; Caillat-Zucman S; Boitard C; Timsit J; Dubois-Laforgue D
    Diabetes Metab; 2013 May; 39(3):244-9. PubMed ID: 23522731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
    Stayoussef M; Benmansour J; Al-Jenaidi FA; Said HB; Rayana CB; Mahjoub T; Almawi WY
    Clin Vaccine Immunol; 2011 Jun; 18(6):990-3. PubMed ID: 21490167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features.
    Grasso YZ; Reddy SK; Rosenfeld CR; Hussein WI; Hoogwerf BJ; Faiman C; Gupta MK
    Endocr Pract; 2001; 7(5):339-45. PubMed ID: 11585368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
    Desailloud R; Fajardy I; Vambergue A; Prevost G; Pigny P; Fontaine P
    Diabetes Metab; 2000 Nov; 26(5):353-60. PubMed ID: 11119014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
    Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
    Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
    Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
    Kawasaki E; Kuriya G; Satoh T; Fujishima K; Moriuchi A; Fukushima K; Ozaki M; Abiru N; Yamasaki H; Eguchi K
    Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
    Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
    Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
    Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
    Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
    Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GAD antibody in IDDM].
    Yokota I; Shima K
    Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
    Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
    J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.